End-stage renal disease after high-dose carboplatinum in preparation of autologous stem cell transplantation

Pediatric Transplantation

Volumn 7, Issue 5, 2003, Pages 408-412

  Butani, Lavjay ^a   West, Daniel C ^a   Taylor, Douglas S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplantation; Carboplatinum; Hemodialysis; Ifosfamide; Nephrotoxicity; Renal failure

Indexed keywords

CALCINEURIN INHIBITOR; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CHRONIC KIDNEY FAILURE; DISEASE COURSE; DRUG MEGADOSE; EWING SARCOMA; FEMALE; FEVER; HUMAN; HYPOKALEMIA; HYPONATREMIA; KIDNEY FAILURE; METASTASIS; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; POLYURIA; SALT LOSING NEPHRITIS; SOLID TUMOR; STEM CELL TRANSPLANTATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CARBOPLATIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SARCOMA, EWING'S; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0142054918     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2003.00071.x     Document Type: Article

References (28)

1. HAWKINS DS, FELGENHAUER J, PARK J, et al. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Cancer 2002: 95: 1354-1365.
2. GRoss TG, EGELER RM, SMITH FO. Pediatric hematopoietic stem cell transplantation. Hematol Oncol Clin North Am 2001: 15: 795-808.
3. COHEN EP. Renal failure after bone-marrow transplantation. Lancet 2001: 357: 6-7.
4. KIST-VAN HOLTHE JE, VAN ZWET JM, BRAND R, VAN WEEL MH, VOSSEN JM, VAN DER HEIJDEN AJ. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998: 22: 559-564.
5. GRIGG A, SZER J, SKOV K, BARNETT M. Multi-organ dysfunction associated with high-dose carboplatin therapy prior to autologous transplantation. Bone Marrow Transplant 1996: 17: 67-74.
6. SCHWARTZ GJ, BRION LP, SPITZER A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987: 34: 571-590.
7. ZAGER RA, O'QUIGLEY J, ZAGER BK, et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 1989: 13: 210-216.
8. SHEA TC, STORNIOLO AM, MASON JR, et al. A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue. Semin Oncol 1992: 19: 139-144.
9. DERAY G, BEN-OTHMAN T, BRILLET G, et al. Carboplatin-induced acute renal failure. Am J Nephrol 1990: 10: 431-432.
10. FRENKEL J, KOOL G, DE KRAKER J. Acute renal failure in high dose carboplatin chemotherapy. Med Pediatr Oncol 1995: 25: 473-474.
11. AGRAHARKAR M, NERENSTONE S, PALMISANO J, KAPLAN AA. Carboplatin-related hematuria and acute renal failure. Am J Kidney Dis 1998: 32: E5.
12. ELLAS AD, AYASH LJ, WHEELER C, et al. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. Bone Marrow Transplant 1995: 15: 373-379.
13. WRIGHT JE, ELIAS A, TRETYAKOV O, et al. High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity. Cancer Chemother Pharmacol 1995: 36: 345-351.
14. BEYER J, RICK O, WEINKNECHT S, KINGREEN D, LENZ K, SIEGERT W. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Bone Marrow Transplant 1997: 20: 813-819.
15. DIMOPOULOS MA, DELIVELIOTIS C, MOULOPOULOS LA, et al. Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel. Urology 1998: 52: 56-60.
16. SHORE R, GREENBERG M, GEARY D, KOREN G. Iphosphamide-induced nephrotoxicity in children. Pediatr Nephrol 1992: 6: 162-165.
17. ARNDT C, MORGENSTERN B, HAWKINS D, WILSON D, LIEDTKE R, MISER J. Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma. Med Pediatr Oncol 1999: 32: 93-96.
18. SKINNER R, PEARSON AD, ENGLISH MW, et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996: 348: 578-580.
19. PRASAD VK, LEWIS IJ, APARICIO SR, et al. Progressive glomerular toxicity of ifosfamide in children. Med Pediatr Oncol 1996: 27: 149-155.
20. KRAMER A, GOLDSCHMIDT H, HAHN U, ANDRASSY K. Progressive renal failure in two breast cancer patients after high-dose ifosfamide. Lancet 1994: 344: 1569.
21. BISHOP JF. Current experience with high-dose carboplatin therapy. Semin Oncol 1992: 19: 150-154.
22. THOMAS H, BODDY AV, ENGLISH MW, et al. Prospective validation of renal function-based carboplatin dosing in children with cancer: a United Kingdom Children's Cancer Study Group Trial. J Clin Oncol 2000: 18: 3614-3621.
23. JODRELL DI, EGORIN MJ, CANETTA RM, et al. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 1992: 10: 520-528.
24. COLBY C, KOZIOL SL, MCAFEE SL, YEAP B, SPITZER TR. High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant. Bone Marrow Transplant 2002: 29: 467-472.
25. CALVERT AH, NEWELL DR, GUMBRELL LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989: 7: 1748-1756.
26. MARINA NM, RODMAN J, SHEMA SJ, et al. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol 1993: 11: 554-560.
27. ROSSI R, GODDE A, KLEINEBRAND A, et al. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 1994: 12: 159-165.
28. JACOBSON P, WEST N, HUTCHINSON RJ. Predictive ability of creatinine clearance estimate models in pediatric bone marrow transplant patients. Bone Marrow Transplant 1997: 19: 481-485.